These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 35987619)

  • 1. Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review.
    Tabesh E; Soheilipour M; Rezaeisadrabadi M; Zare-Farashbandi E; Mousavi-Roknabadi RS
    BMC Gastroenterol; 2022 Aug; 22(1):393. PubMed ID: 35987619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methanol poisoning during COVID-19 pandemic; A systematic scoping review.
    Mousavi-Roknabadi RS; Arzhangzadeh M; Safaei-Firouzabadi H; Mousavi-Roknabadi RS; Sharifi M; Fathi N; Zarei Jelyani N; Mokdad M
    Am J Emerg Med; 2022 Feb; 52():69-84. PubMed ID: 34883289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of SARS-CoV-2 vaccination in patients with inflammatory bowel disease: A systematic review and meta-analysis.
    James D; Jena A; Bharath PN; Choudhury A; Singh AK; Sebastian S; Sharma V
    Dig Liver Dis; 2022 Jun; 54(6):713-721. PubMed ID: 35382972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID-19 (SARS-CoV-2) disease: A systematic scoping review.
    Mousavi-Roknabadi RS; Haddad F; Fazlzadeh A; Kheirabadi D; Dehghan H; Rezaeisadrabadi M
    J Med Virol; 2021 Oct; 93(10):5742-5755. PubMed ID: 34228355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 vaccination rate and willingness of an additional dose among inflammatory bowel disease patients receiving biologic therapy: Fearless and with desire.
    Ramos L; Carrillo-Palau M; Alonso-Abreu I; Reygosa C; Hernández-Alvarez N; Amaral C; Hernández A; Benítez-Zafra F; Pérez-González F; Quintana-Díaz H; Hernandez-Guerra M
    Gastroenterol Hepatol; 2023 Apr; 46(4):255-260. PubMed ID: 35609791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review Article: vaccination for patients with inflammatory bowel disease during the COVID-19 pandemic.
    Doherty J; Fennessy S; Stack R; O' Morain N; Cullen G; Ryan EJ; De Gascun C; Doherty GA
    Aliment Pharmacol Ther; 2021 Nov; 54(9):1110-1123. PubMed ID: 34472643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Durability of COVID-19 Vaccination in 9447 Patients With IBD: A Systematic Review and Meta-Analysis.
    Jena A; James D; Singh AK; Dutta U; Sebastian S; Sharma V
    Clin Gastroenterol Hepatol; 2022 Jul; 20(7):1456-1479.e18. PubMed ID: 35189387
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Side Effects of COVID-19 Vaccines in Patients with Inflammatory Bowel Disease in Japan.
    Miyazaki H; Watanabe D; Ito Y; Okamoto N; Tokunaga E; Ku Y; Ooi M; Hoshi N; Kodama Y
    Dig Dis Sci; 2023 Feb; 68(2):564-570. PubMed ID: 36178566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation and Short-term Adverse Events of Anti-SARS-CoV-2 Vaccines in Inflammatory Bowel Disease Patients: An International Web-based Survey.
    Ellul P; Revés J; Abreu B; Chaparro M; Gisbert JP; Allocca M; Fiorino G; Barberio B; Zingone F; Pisani A; Cassar D; Michalopoulos G; Mantzaris G; Koutroubakis I; Karmiris K; Katsanos K; Ďuricova D; Burisch J; Madsen GR; Maaser C; Naila A; Orfanoudaki E; Milivojevic V; Buisson A; Avedano L; Leone S; Torres J
    J Crohns Colitis; 2022 Aug; 16(7):1070-1078. PubMed ID: 35037033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Vaccination in IBD: Past Lessons, Current Evidence, and Future Challenges.
    Wellens J; Colombel JF; Satsangi JJ; Wong SY
    J Crohns Colitis; 2021 Aug; 15(8):1376-1386. PubMed ID: 33721882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in inflammatory bowel disease infections and vaccinations in the past four decades: A high-level text mining analysis of PubMed publications.
    Klang E; Soffer S; Shachar E; Lahat A
    Hum Vaccin Immunother; 2022 Nov; 18(5):2065814. PubMed ID: 35471850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes towards COVID-19 vaccination in patients with inflammatory bowel disease.
    Duong TA; Bryant RV; Andrews JM; Lynch KD
    Intern Med J; 2022 Jun; 52(6):1070-1074. PubMed ID: 35583312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
    Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
    Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION.
    Queiroz NSF; Teixeira FV; Freire CCF; Motta MP; Vasconcellos MAM; Chebli LA; Saad-Hossne R;
    Arq Gastroenterol; 2021; 58(1):1-4. PubMed ID: 33909805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2-mRNA Booster Vaccination Reverses Non-Responsiveness and Early Antibody Waning in Immunocompromised Patients - A Phase Four Study Comparing Immune Responses in Patients With Solid Cancers, Multiple Myeloma and Inflammatory Bowel Disease.
    Wagner A; Garner-Spitzer E; Schötta AM; Orola M; Wessely A; Zwazl I; Ohradanova-Repic A; Weseslindtner L; Tajti G; Gebetsberger L; Kratzer B; Tomosel E; Kutschera M; Tobudic S; Pickl WF; Kundi M; Stockinger H; Novacek G; Reinisch W; Zielinski C; Wiedermann U
    Front Immunol; 2022; 13():889138. PubMed ID: 35634285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of COVID-19 on Patients with Inflammatory Bowel Disease.
    Kogan L; Ungaro RC; Caldera F; Shah SA
    R I Med J (2013); 2022 Dec; 105(10):42-47. PubMed ID: 36413451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.
    Alhumaid S; Al Mutair A; Rabaan AA; ALShakhs FM; Choudhary OP; Yong SJ; Nainu F; Khan A; Muhammad J; Alhelal F; Al Khamees MH; Alsouaib HA; Al Majhad AS; Al-Tarfi HR; ALyasin AH; Alatiyyah YY; Alsultan AA; Alessa ME; Alessa ME; Alissa MA; Alsayegh EH; Alshakhs HN; Al Samaeel HA; AlShayeb RA; Alnami DA; Alhassan HA; Alabdullah AA; Alhmed AH; AlDera FH; Hajissa K; Al-Tawfiq JA; Al-Omari A
    BMC Gastroenterol; 2022 Oct; 22(1):433. PubMed ID: 36229799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Prospective Questionnaire-Based Study to Evaluate Factors Affecting the Decision to Receive COVID-19 Vaccination in 267 Patients with Inflammatory Bowel Disease in Poland.
    Łodyga M; Maciejewska K; Rydzewska G
    Med Sci Monit; 2022 Dec; 28():e938665. PubMed ID: 36474411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of SARS-CoV-2 Vaccination in a Veterans Affairs Cohort of Patients With Inflammatory Bowel Disease With Diverse Exposure to Immunosuppressive Medications.
    Khan N; Mahmud N
    Gastroenterology; 2021 Sep; 161(3):827-836. PubMed ID: 34048782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.